Search

Your search keyword '"Belli, L."' showing total 905 results

Search Constraints

Start Over You searched for: Author "Belli, L." Remove constraint Author: "Belli, L."
905 results on '"Belli, L."'

Search Results

1. Data Integration in a Smart City: A Real Case

3. The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients

4. Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation

5. Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation

6. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

7. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

8. Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

9. New-Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine-Induced Thrombotic Thrombocytopenia

13. Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C

14. Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

15. COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study

16. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation

17. Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection

18. Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

20. Outcomes of Liver Transplant for Adults With Wilson’s Disease

21. Recent trends and intention-to-treat survival of liver transplantation for nonalcoholic steatohepatitis: an Italian liver transplant registry study

22. Impact of COVID-19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry

23. Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

24. Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

25. Long‐term outcomes of direct acting antivirals in post‐transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis

27. SARS-CoV-2 infection in liver transplantation is associated with favorable outcomes: an Italian transplant registry study

30. Is the use of marginal donors justified in liver transplantation? Analysis of results and proposal of modern criteria

31. Liver transplantation for primary sclerosing cholangitis

32. Development of a model based on case-mix analysis to predict 6-month patient survival after liver transplantation: a multicenter Italian study

33. Different perceptions of sustainable case-mix for liver transplantation between surgeons and hepatologists: an Italian multicenter study

34. Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

37. Liver transplantation for hepatocellular carcinoma: prognostic factors associated long-term survival

38. Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology

39. Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA/ELTR multi-center European study

40. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS)

41. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

42. RecSys 2021 challenge workshop : Fairness-aware engagement prediction at scale on Twiter's Home Timeline

46. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis

47. Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

48. The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities

49. High rates of 30-day mortality in patients with cirrhosis and COVID-19

50. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience

Catalog

Books, media, physical & digital resources